This Investment Digest summarizes key observations in the private equity and venture capital ecosystem,as well as public companies of the rapidly evolving and exponentially growing Longevity Industry.

This edition assembled information about key industry trends, more than 50,000 Longevity companies, 50 leading investors, and 495 Longevity-focused publicly traded corporations.

There have also been outlined major investment rounds and relevant R&D trends, illustrating the industry’s traction and readiness of institutional investors to potentially acquire the most successful startups, such as AgeTech, Longevity Fintech, and Longevity Biomedicine.